OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 58 filers reported holding OBALON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,944,000 | -32.3% | 2,044,440 | -2.6% | 1.17% | -34.1% |
Q4 2018 | $4,347,000 | -23.3% | 2,100,000 | 0.0% | 1.77% | +9.5% |
Q3 2018 | $5,670,000 | +151.1% | 2,100,000 | +100.0% | 1.62% | +114.2% |
Q2 2018 | $2,258,000 | +54.9% | 1,050,000 | +147.1% | 0.76% | +8.9% |
Q1 2018 | $1,458,000 | -63.5% | 425,000 | -29.6% | 0.69% | -68.2% |
Q4 2017 | $3,993,000 | -23.5% | 604,036 | +10.3% | 2.18% | -31.8% |
Q3 2017 | $5,218,000 | -0.3% | 547,536 | +3.7% | 3.20% | +4.6% |
Q2 2017 | $5,233,000 | -13.5% | 528,066 | -6.7% | 3.06% | -19.2% |
Q1 2017 | $6,050,000 | +21.5% | 565,912 | +0.6% | 3.78% | +7.3% |
Q4 2016 | $4,979,000 | – | 562,606 | – | 3.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|